Carbon dioxide insufflation in colonoscopy is safe: a prospective trial of 347 patients by Geyer, M. et al.
Hindawi Publishing Corporation
Diagnostic and Therapeutic Endoscopy
Volume 2012, Article ID 692532, 4 pages
doi:10.1155/2012/692532
Clinical Study
Carbon Dioxide Insufflation in Colonoscopy Is Safe:
A Prospective Trial of 347 Patients
M. Geyer,1 U. Guller,2, 3 and Ch. Beglinger4
1 Gastroenterologie Wettingen, Rosengartenstrasse 2, 5430 Wettingen, Switzerland
2 Department of Oncology, Kantonsspital, 9007 St. Gallen, Switzerland
3 Department of Visceral Surgery and Medicine, University Hospital Bern, 3010 Bern, Switzerland
4 Department of Gastroenterology, University Hospital, 4031 Basel, Switzerland
Correspondence should be addressed to M. Geyer, geyer@gastroenterologie-wettingen.ch
Received 1 June 2012; Revised 16 August 2012; Accepted 29 August 2012
Academic Editor: Jean-Marc Dumonceau
Copyright © 2012 M. Geyer et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Available evidence suggests that the use of CO2 insufflation in endoscopy is more comfortable for the patient. The safety of
CO2 use in colonoscopy remains contentious, particularly in sedated patients. The objective of the present prospective trial was
to assess the safety of CO2 colonoscopies. Methods. 109 patients from our previous randomized CO2 colonoscopy study and
an additional 238 subsequent consecutive unselected patients who had a routine colonoscopy performed in a private practice
were enrolled from April 2008 through September 2008. All but 2 patients were sedated. All patients were routinely monitored
with transcutaneous CO2 measurement. Volumes of CO2 administered were correlated with capnographic measurements from
transcutaneous monitoring. Results. Of the 347 patients examined, 57% were women; mean (SD) age of participants was of 60.2
years (12.8). Mean propofol dosage was 136mg (64mg). Mean CO2 values were 34.7mm Hg (5.3) at baseline, 38.9mm Hg (5.5)
upon reaching the ileum, and 36.9mm Hg (5.0) at examination’s end. Mean maximum increase of CO2 was 4.5mm Hg (3.6).
No correlation was observed between volume of CO2 administered and increase in level of CO2 (correlation coefficient: 0.01; P
value: 0.84). No complications were observed. Conclusions. The present prospective study, which was based on one of the largest
sedated patient sample reported to date in this setting, provides compelling evidence that CO2 insufflation in colonoscopy is safe
and unassociated with relevant increases in transcutaneously measured levels of CO2.
1. Background
For almost 2 decades, CO2 insufflation with carbon dioxide
(CO2) has been widely used in laparoscopic surgery. In con-
trast, insufflation with room air has remained the standard of
care in the vast majority of endoscopy centers in both Europe
and North America. Unfortunately, many patients still
experience pain and discomfort after colonoscopy with room
air insufflation. Studies [1–5] and one review [6] indicate
that insufflation with CO2 can reduce periprocedural pain
in different endoscopic settings (e.g., endoscopic retrograde
cholangio-pancreatography [7], balloon enteroscopy [8],
and endoscopic submucosal dissection [9]). However, in the
setting of colonoscopy, current scientific data with regard
to the safety of CO2 insufflation are limited. Small patient
populations have characterized most studies, including those
with sedated patients, and many physicians remain con-
cerned that CO2 insufflation might lead to CO2 retention.
In a previous randomized, controlled, double-blinded trial,
we randomly allocated 219 patients to colonoscopy with
CO2 versus room air, patients in the CO2 group experienced
significantly less pain and bloating and a higher overall
satisfaction score [10]. However, this study was not designed
to definitively demonstrate the safety of CO2 insufflation in
colonoscopy. In the present study, we sought to prospectively
assess the safety of CO2 colonoscopy in a larger sample of
patients.
2. Patients and Methods
This trial included all 109 patients from our previous CO2
colonoscopy study [10] plus 238 subsequent, consecutive,s
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nonselected, patients who had a routine colonoscopy per-
formed in a private Swiss gastroenterology practice and
were enrolled from April 2008 through September 2008. All
patients who were deemed medically fit for an ambulatory
colonoscopy were included in this study. In order to max-
imize the generalizability (external validity) of our study,
we did not initially apply exclusion criteria, although one
exclusion criterion emerged (due to a small earlap, CO2
measurement was not possible in 4 patients, which were
excluded). All colonoscopies were done by the first author
(M. G.) and carried out with standard Pentax endoscopes
(EC-3885K and EC-380FKp) (Pentax Medical, Pentax of
America, Inc., Montvale, NJ, USA) with an EPK 1000
processor. For CO2 insufflation, the CO2-Efficent Insufflator
device (EZEM Company, Westbury, NY, USA) was used.
The insufflator was connected to a 10-litre CO2 bottle
and supplied over a tubing set connected with a branch
connection to the water bottle tube, which was itself directly
connected to the endoscope. The flow rate (basal flow
rate 0.5 L/min, increasing to 3 L/min maximum) can be
controlled on demand over the standard air valve. Oxygen
was delivered to patients if the saturation dropped below
90% at a flow rate of 4 liters per minute.
All but 2 patients were sedated with propofol using
standard procedures previously described [11]. The total
dose of propofol was registered for later analysis. A level of
conscious sedation (“moderate sedation”) was targeted. All
patients were routinely monitored with transcutaneous CO2
measurement on the ear, with the exception of those patients
who were excluded due to insufficient earlap (n = 4). CO2
measurement was performed with the SenTec capnograph
(SenTec AG, 4106 Therwil, Switzerland) as described by
Heuss et al. [12]. Our measurement technique followed
that recommended by SenTec; internal validation was not
performed as the system has been previously extensively
validated [12–14]. Sensors were calibrated according to
mandatory procedure and placed on the earlap after cleaning
with 70% isopropyl alcohol solution and application of
contact liquid on the sensor membrane.
In previous validation studies, correlation of partial
pressure of CO2 (paCO2) and transcutaneous CO2 mea-
surement was as follows: r = 0.92; intraclass correlation
coefficient [ICC] = 0.92; for arterial saturation of oxygen
(SaO2/SpO2), r = 0.74; ICC = 0.73 [14]. Data for continuous
transcutaneous CO2 measurements were analyzed, as were
baseline characteristics including age, propofol use, and
CO2 volume administered. To ensure validity of our mea-
surements, we analyzed and compared the 238 consecutive
patients separately, with the 109 patients derived from our
earlier CO2 study using an unpaired t-test. Additionally the
correlation of the insufflated amount of CO2 with a possible
increase of transcutaneously measured CO2 was assessed
using Spearman correlations. Statistical analyses were per-
formed using SPSS, v. 11.0 (IBM Corp., Armonk, NY, USA).
3. Results
The first sample of 109 patients who received CO2
insufflation for colonoscopy was drawn from our previous
Table 1: Results (mean ± SD)1.
1st sample
(n = 109)
2nd sample
(n = 238)
All
(n = 347)
Sex, female 62% 55% 57%
Propofol (mg) 134± 56 137± 68 136± 64
CO2 start (mmHg) 33.4± 4.7 35.4± 5.4 34.7± 5.3
CO2 ileum (mmHg) 37.3± 5.2 39.6± 5.5 38.9± 5.5
CO2 end (mmHg) 35.2± 4.3 37.7± 5.1 36.9± 5.0
Amount CO2 (L) 51± 14 47± 15 48± 15
1
All P values > 0.05.
study, which was conducted from April to June of 2008. All
subsequent patients referred for colonoscopy at this single
practice were routinely examined with CO2, with the result
that from June 2008 through September 2008, an additional
238 patients (second sample) were examined using CO2
insufflation, for a final study population of 347. Of the 347
patients examined, 198 (57%) were female; the mean (SD)
age was 60 years (12.8). Mean (SD) propofol dosage was
136mg (64) (Table 1); mean (SD) duration of endoscopy
procedures was 24 minutes (7.5). All but 2 patients in the
second sample were sedated. Mean (SD) value for baseline
CO2 measurement was 34.7mmHg (5). Mean (SD) pressure
of CO2 recorded reaching the ileum was 38.9mmHg (5) and
36.9mmHg (5) at the end of the examination (Figure 1).
Mean maximum increase of CO2 pressure was 4.4mmHg
(Figure 2).
Four patients in the second sample experienced transient
pCO2 values in excess of 50mmHg (three when reaching
the ileum and one at the end of the examination), but
these patients showed no signs of respiratory distress or O2
desaturation and O2 substitution was not deemed necessary.
These four patients did not receive a higher propofol dosage
or volume of CO2 insufflated.
Among the total study sample, no correlation was
observed between volume of CO2 administered and an
increase of CO2 (correlation coefficient: 0.01; P-value: 0.84)
(Figure 3). Parameters did not significantly differ between
the first and second samples. None of the patients required
ventilation or mechanical airway support, and no other
complications (bleeding, perforation, loss of consciousness,
hospital admission) were observed.
4. Discussion
The present prospective study, which was based on one of
the largest sample of sedated patients to date, provides com-
pelling evidence that CO2 insufflation colonoscopy is safe
and is not associated with an increase in transcutaneously
measured CO2 or with adverse respiratory effects. Our
findings add to mounting scientific evidence demonstrating
the safety and superiority of CO2 colonoscopy over room
air [6, 10]. Given these findings, we believe that CO2
colonoscopy should be considered the procedure of choice.
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Figure 2: Increase in CO2 (mmHg).
Although CO2 insufflation has been used for different
endoscopic procedures [1–9] and was found to be associated
with less postprocedural pain and bloating [10, 15], most
endoscopy units continue to use room air for screening
colonoscopies and are unaware of the benefits of this
relatively new technique [16].
In our first double-blinded randomized study—hitherto
the largest reported sample of sedated and CO2 monitored
patients—239 patients were randomly allocated in a 1 : 1
ratio to colonoscopy with CO2 versus room air. This
study, which represented the first examination of sedated,
unselected, and consecutive patients in this setting, yielded
encouraging results: no difference in transcutaneous CO2
values was observed with continuous capnography between
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Figure 3: Correlation of CO2 change and insufflated CO2 volume.
groups, and there was no evidence of advanced hypercapnia
as a possible problem with this technique [10]. However, we
felt that this initial experience from our group needed to
be confirmed in a study with larger sample size. By incor-
porating patients randomized to CO2 insufflation in that
previous study and an additional 238 consecutive patients,
we achieved an even larger patient population, providing
compelling evidence for the safety of CO2 insufflation in
sedated and monitored patients undergoing colonoscopy.
Only 4 patients experienced a partial pressure of CO2 in
excess of 50mm Hg (max. paCO2 52.8mmHg).
Our study shows that sedated patients had a small
increase in CO2 during colonoscopy until the terminal
ileum was reached, after which CO2 levels fell. We speculate
from these observations that sedation per se, but not CO2
insufflation in particular, appears to be the primary cause of
the observed CO2 increase during colonoscopy.
Many patients with severe chronic obstructive pul-
monary disease (COPD) experience CO2 retention, an
inherent phenomenon of this disease. Until now, no studies
have been performed to assess whether CO2 is also safe
to use in this high-risk population. But although COPD
patients included in our study suffered no relevant adverse
outcomes, they constituted only a small percentage of the
study population and larger studies of CO2 insufflation in
patients with COPD should be performed to confirm its
safety in this subset of patients.
A particularly noteworthy finding of this study is the
lack of correlation between volume of insufflated CO2
and the increase of CO2 as measured by transcutaneous
monitoring. Because CO2 is very quickly exhaled, paCO2
never reached clinically toxic value. It might be influenced
more by individual factors not yet fully understood than by
the amount of insufflated CO2.
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Because CO2 is absorbed into the bloodstream 150 times
faster than room air and also exhaled with an elimination
of 0.2 L per minute [17], higher volumes of gas (e.g., 51 L
[±14 L]) are usually needed when using CO2 for colonoscopy
insufflation, compared with room air [18]. Some physicians
who are already using CO2 insufflation for colonoscopy
believe that briefly switching from CO2 to room air to obtain
a faster and better colonic distension can be useful in certain
circumstances. This may be due to the fact that the flow rates
of all commercial available CO2 insufflators are still below the
usual rates achieved with air insufflators.
From a practical point of view, there are no clinically
relevant problems in handling CO2 insufflation with modern
insufflators; further, we believe that no safety concerns
remain in patients devoid of COPD.
5. Conclusion
The present prospective study, which was based on one of
the largest sedated patient sample reported to date, provides
compelling evidence that colonoscopy with CO2 insufflation
is safe in patients devoid of COPD. Neither a relevant
increase in transcutaneously measured CO2 nor adverse
respiratory effects were detected.
Acknowledgment
The authors thank Jonathan McCall, M. S., for critically
reviewing this paper andmaking many valuable suggestions.
References
[1] M. Bretthauer, A. B. Lynge, E. Thiis-Evensen, G. Hoff, O.
Fausa, and L. Aabakken, “Carbon dioxide insufflation in
colonoscopy: safe and effective in sedated patients,” Endoscopy,
vol. 37, no. 8, pp. 706–709, 2005.
[2] M. Bretthauer, E. Thiis-Evensen, G. Huppertz-Hauss et al.,
“NORCCAP (Norwegian colorectal cancer prevention): a
randomised trial to assess the safety and efficacy of carbon
dioxide versus air insufflation in colonoscopy,” Gut, vol. 50,
no. 5, pp. 604–607, 2002.
[3] A. M. J. Hussein, C. I. Bartram, and C. B. Williams, “Carbon
dioxide insufflation for more comfortable colonoscopy,” Gas-
trointestinal Endoscopy, vol. 30, no. 2, pp. 68–70, 1984.
[4] K. Sumanac, I. Zealley, B. M. Fox et al., “Minimizing
postcolonoscopy abdominal pain by using CO(2) insufflation:
a prospective, randomized, double blind, controlled trial
evaluating a new commercially available CO(2) delivery
system.,” Gastrointestinal endoscopy, vol. 56, no. 2, pp. 190–
194, 2002.
[5] J. C. H. Wong, K. K. Yau, H. Y. S. Cheung, D. C. T. Wong, C.
C. Chung, and M. K. W. Li, “Towards painless colonoscopy:
a randomized controlled trial on carbon dioxide-insufflating
colonoscopy,” ANZ Journal of Surgery, vol. 78, no. 10, pp. 871–
874, 2008.
[6] E. S. Dellon, J. S. Hawk, I. S. Grimm, and N. J. Shaheen, “The
use of carbon dioxide for insufflation during GI endoscopy: a
systematic review,” Gastrointestinal Endoscopy, vol. 69, no. 4,
pp. 843–849, 2009.
[7] M. Bretthauer, B. Seip, S. Aasen, M. Kordal, G. Hoff, and L.
Aabakken, “Carbon dioxide insufflation for more comfortable
endoscopic retrograde cholangiopancreatography: a random-
ized, controlled, double-blind trial,” Endoscopy, vol. 39, no. 1,
pp. 58–64, 2007.
[8] D. Domagk, M. Bretthauer, P. Lenz et al., “Carbon dioxide
insufflation improves intubation depth in double-balloon
enteroscopy: a randomized, controlled, double-blind trial,”
Endoscopy, vol. 39, no. 12, pp. 1064–1067, 2007.
[9] S. Yutaka, U. Toshio, M. Takahisa et al., “A pilot study to assess
the safety and efficacy of carbon dioxide insufflation during
colorectal endoscopic submucosal dissection with the patient
under conscious sedation,” Gastrointestinal Endoscopy, vol. 65,
no. 3, pp. 537–542, 2007.
[10] M. Geyer, U. Guller, and C. Beglinger, “Carbon dioxide
insufflation in routine colonoscopy is safe and more comfort-
able: results of a randomized controlled double-blinded trial,”
Diagnostic and Therapeutic Endoscopy, vol. 2011, Article ID
378906, 6 pages, 2011.
[11] L. T. Heuss, P. Schnieper, J. Drewe, E. Pflimlin, and C.
Beglinger, “Risk stratification and safe administration of
propofol by registered nurses supervised by the gastroenterol-
ogist: a prospective observational study of more than 2000
cases,” Gastrointestinal Endoscopy, vol. 57, no. 5, pp. 664–671,
2003.
[12] L. T. Heuss, P. N. Chhajed, P. Schnieper, T. Hirt, and
C. Beglinger, “Combined pulse oximetry/cutaneous carbon
dioxide tension monitoring during colonoscopies: pilot study
with a smart ear clip,” Digestion, vol. 70, no. 3, pp. 152–158,
2004.
[13] R. Roediger, B. Beck-Schimmer, O. M. Theusinger et al., “The
revised digital transcutaneous PCO2/SpO2 ear sensor is a
reliable noninvasive monitoring tool in patients after cardiac
surgery,” Journal of Cardiothoracic and Vascular Anesthesia, vol.
25, no. 2, pp. 243–249, 2011.
[14] C. Domingo, E. Canturri, M. Luja´n, A. Moreno, H. Espuelas,
and A. Marı´n, “Transcutaneous measurement of partial
pressure of carbon dioxide and oxygen saturation: validation
of the SenTec monitor,” Archivos de Bronconeumologia, vol. 42,
no. 5, pp. 246–251, 2006.
[15] J. Wu and B. Hu, “The role of carbon dioxide insufflation
in colonoscopy: a systematic review and meta-analysis,”
Endoscopy, vol. 44, no. 2, pp. 128–136, 2012.
[16] F. Janssens, J. Deviere, P. Eisendrath, and J. M. Dumon-
ceau, “Carbon dioxide for gut distension during digestive
endoscopy: technique and practice survey,” World Journal of
Gastroenterology, vol. 15, no. 12, pp. 1475–1479, 2009.
[17] H. A. Saltzman and H. O. Sieker, “Intestinal response to
changing gaseous environments: normobaric and hyperbaric
observations.,”Annals of the New York Academy of Sciences, vol.
150, no. 1, pp. 31–39, 1968.
[18] M. Bretthauer, G. S. Hoff, E. Thiis-Evensen, G. Huppertz-
Hauss, and E. Skovlund, “Air and carbon dioxide volumes
insufflated during colonoscopy,” Gastrointestinal Endoscopy,
vol. 58, no. 2, pp. 203–206, 2003.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
